COMPOUND PROFILE / SMALL MOLECULES
5-Amino-1MQ.
Research draft5-Amino-1MQ is an experimental small-molecule NNMT inhibitor.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
5-Amino-1MQ is an experimental small-molecule NNMT inhibitor.
Mechanism
It inhibits nicotinamide N-methyltransferase, affecting metabolic pathways in experimental models.
Human research
A credible therapeutic human evidence base was not established.
Preclinical & other research
Mouse obesity experiments reported metabolic effects; these cannot establish human fat loss.
Safety & unknowns
Human pharmacokinetics, adverse effects and long-term consequences remain unresolved.
Regulatory status
Research compound; not a peptide or established weight-loss medicine.
Reported use & evidence
The supplied 5-Amino-1MQ profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.